TA-1 5mg Immune Signalling Research Peptide

Thymosin Alpha-1 (TA-1), also known as thymalfasin, is a naturally occurring 28-amino-acid peptide originally identified through research into the thymus gland.

TA-1 has attracted significant scientific interest for its role in immune regulation, particularly its interactions with T-cell activity, cytokine signalling and immune response pathways.

Unlike peptides primarily associated with metabolic or tissue-repair research, Thymosin Alpha-1 is investigated for its potential influence on both innate and adaptive immune mechanisms.

Suitable For Research On

• Immune signalling pathways

• T-cell activation and differentiation

• Innate and adaptive immune responses

• Cytokine regulation

• Dendritic cell activity

• Immunomodulation research models

Why Researchers Study Thymosin Alpha-1

• Naturally occurring 28-amino-acid peptide

• Established history in immunology research

• Studied in both laboratory and clinical settings

• Investigated for interactions with multiple immune pathways

• Recognised in scientific literature as thymalfasin

Key Research Areas

Immune System Regulation

Thymosin Alpha-1 has been investigated for its interactions with immune cells and signalling mechanisms involved in coordinating immune responses.

T-Cell Research

Researchers study how TA-1 influences T-cell development, activation and function within adaptive immune pathways.

Cytokine Signalling

TA-1 has been examined for its potential effects on cytokine production and communication between immune cells.

Innate Immunity

Research also explores TA-1's interactions with dendritic cells and other components of the innate immune system.

Compound Information

• Compound: Thymosin Alpha-1

• Alternative name: Thymalfasin, Tα1, TA-1

• Peptide length: 28 amino acids

• Molecular formula: C₁₂₉H₂₁₅N₃₃O₅₅

• Molecular weight: Approximately 3,108 Da

• Research category: Immunology and immune signalling

Frequently Asked Questions

What is Thymosin Alpha-1?

Thymosin Alpha-1 is a naturally occurring peptide studied for its interactions with immune cells and signalling pathways.

What is the difference between TA-1 and thymalfasin?

Thymosin Alpha-1 refers to the peptide itself, while thymalfasin is the name commonly used for its synthetic pharmaceutical form.

What is Thymosin Alpha-1 being researched for?

Studies have investigated TA-1 in immune regulation, infectious diseases, cancer-related immune responses and inflammatory conditions. Clinical outcomes vary between research settings, and its medical effectiveness has not been established for all proposed applications.

Is Thymosin Alpha-1 approved in Australia?

The Australian regulatory status of a specific TA-1 product must be verified through the Therapeutic Goods Administration. Research interest or international clinical use does not establish Australian approval.

Important Notice

Thymosin Alpha-1 is being investigated in scientific and clinical research. Its effects on laboratory immune markers should not be interpreted as proof of clinical benefits.

This information is provided for scientific reference only and does not constitute medical advice or recommend human use.

The regulatory status of any TA-1 product must be established before it is advertised or supplied in Australia.